Soaring Tri Calcium Phosphate in India, Provide No Relief to Indian Pharma Industry
Indian Pharma industry has been facing difficulties since a long time due to spiralling raw material cost. Production halts across China and high freight cost in global market have made it difficult for domestic manufacturers to procure cargoes on time and at a reasonable cost since past several months. One of the important raw material Tri Calcium Phosphate remained at a very high note during October-November timeframe, leaving downstream users anxious about profitability. Furthermore, as per ChemAnalyst data , Tri Calcium Phosphate prices shot up by around 22% within 6 weeks in India, which was highly concerning for downstream users. These circumstances arrived due to lower imports China that too at a very high price quotation. Chinese market recently witnessed several ups and downs due to highly complicated market dynamics, where raw material prices kept on fluctuating with a considerably high margin. Manufacturers in China observed strict regulations imposed by Chinese governmen...